Food Allergy Course logo

Food Allergy: From Primary Prevention to Treatment and Intervention

Chicago, IL US
September 6, 2019 to September 8, 2019

This meeting is sold out. No onsite registrations will be taken.
Check here to order recordings of the program.


This live course will allow participants to increase their knowledge and skills related to the diagnosis and management of food allergic patients. It will highlight the latest evidence related to food allergies, and will include a combination of lectures, small group discussions, and hands-on training to prepare participants to return to their practices prepared to provide optimal care to these patients.


Registration Fees
Attendee TypeAdvance Fee (Through Aug. 23)
AAAAI Member Physician$395
Fellow-in-Training, Resident, Student$50
Nurse, Nurse Practitioner, Physician Assistant, other Allied Health Practitioner$100
Non-Member Physician$495
Cancellations & Refunds

Registration fees will be refunded in full for cancellations made on or before Thursday, August 29, 2019. Cancellations made after this date are not eligible for a refund. Please contact cme@aaaai.org with questions regarding cancellations and refunds.


 

Target Audience

  • Practicing physicians (A/I specialists and others who treat food-allergic patients)
  • Fellows-in-training
  • Nurses
  • Nurse Practitioners
  • Physician Assistants
  • Allied Health practitioners

 

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Apply evidence-based decision making to the diagnosis of food allergic patients
  • Translate into practice the approved guidelines for food allergy prevention
  • Implement effective education strategies related to the prevention and treatment of anaphylaxis
  • Identify and apply the treatment options currently available for patients with food allergies

 


Sponsorship Opportunities

Please click the Sponsorship Prospectus and Sponsorship Floorplan documents, below, for information about sponsorship opportunities for this meeting.


 

Additional Information

Summary
Available credit: 
  • 14.50 Attendance
    Attendance credit.
  • 14.50 CE
    CE credit.
  • 14.50 CME
    CME credit.
Course opens: 
12/17/2018
Course expires: 
06/30/2020
Event starts: 
09/06/2019 - 1:00pm
Event ends: 
09/08/2019 - 11:30am
Cost:
$495.00
Rating: 
0
DateStart TimeEnd TimeName
 9/6/20191:00 PM6:00 PMOverview of Food Allergy Diagnosis and Management
 1:00 PM6:00 PMLectures on Overview of  Food Allergy Diagnosis and Management
 1:00 PM1:40 PMEpidemiology & Natural History of Food Allergy w/ Q&A
 1:40 PM2:20 PMPathophysiology of Food Allergy w/ Q&A
 2:20 PM3:00 PMFood Allergy Cases: Clinical Presentations of Food Allergy w/ Q&A
 3:00 PM3:40 PMFood Allergy Cases: Approach to Diagnosis and Management w/ Q&A
 3:40 PM4:00 PMBreak
 4:00 PM4:40 PMOptimal Use Diagnostic Testing:  Components and Oral Food Challenges w/ Q&A
 4:40 PM5:20 PMAnaphylaxis: Prevention and Management w/ Q&A
 5:20 PM6:00 PMPanel Discussion
    
 9/7/20198:00 AM5:15 PMOverview of Specific Syndromes
 8:00 AM10:00 AMLectures on Specific Syndromes
 8:00 AM8:40 AMNuts and Bolts of Atopic Dermatitis w/ Q&A
 8:40 AM9:20 AMNon IgE Mediated Food Allergy w/ Q&A
 9:20 AM10:00 AMEosinophilic Esophagitis: Optimal Diagnosis and Management w/ Q&A
 10:00 AM10:15 AMBreak
 10:15 AM11:00 AMHands-on and Discussion Breakouts
   What do I need to know? Performing Oral Food Challenges in the Office Setting
   Anaphylaxis Management in Different Settings
   Case Based Approach to Testing for Food Allergy
   Patterns of Cross-Reactivity in Food Allergy
   Risk Management in Oral Food Challenges
   Avoidance Diets & Nutrition
   Essentials of Education for Patients
 11:00 AM11:15 AMBreak
 11:15AM12:00 PMHands-on and Discussion Breakouts
   Oral Food Challenges in the Office Setting
   Anaphylaxis Management in Different Settings
   Case Based Approach to Testing for Food Allergy
   Atopic Dermatitis: Optimal Management and the Role of Food Allergy
   Risk Management in Oral Food Challenges
   Avoidance Diets & Nutrition
   Essentials of Education for Patients
 12:00 PM1:30 PMBreak
 1:45 PM3:45 PMLectures on the Treatment of Food Allergy
 1:45 PM2:25 PMOral Immunotherapy: Integration into Clinical Practice w/ Q&A
 2:25 PM2:50 PMEpicutaneous Immunotherapy w/ Q&A
 2:50 PM3:10 PMThe Role of Omalizumab in Food Allergy w/ Q&A
 3:10 PM3:30 PMPhase I and Phase II Clinical Trials Moving Through FDA Process w/ Q&A
 3:30 PM3:45 PMPanel Discussion
 3:45 PM4:00 PMBreak
 4:00 PM4:45 PMDiscussion Breakouts
 4:00 PM4:45 PMEpicutaneous and Other Treatment Approaches
 4:00 PM4:45 PMOral Immunotherapy
 4:00 PM4:45 PMWhat Happens After the Research Study?
 4:00 PM4:45 PMAvoidance Diets for Atopic Dermatitis and EOE
 4:00 PM4:45 PMIntroduction of Baked Milk and Egg
 4:00 PM4:45 PMFuture Diagnostic Testing
 4:45 PM5:00 PMBreak
 5:00 PM5:45 PMDiscussion Breakouts
 5:00 PM5:45 PMThe Use of Biologics in Food Allergy
 5:00 PM5:45 PMOral Immunotherapy
 5:00 PM5:45 PMIntroduction of Baked Milk and Egg
 5:00 PM5:45 PMComplimentary Medicine and Non-Traditional Approaches to Food Allergy Treatment
 5:00 PM5:45 PMManagement of Severe Atopic Dermatitis
    
 9/8/20198:00 AM12:45 PMNovel Research & Prevention of Food Allergy
 8:00 AM10:00 AMLectures on Novel Research and Prevention of Food Allergy
 8:00 AM8:40 AMPrevention of Peanut Allergy w/ Q&A
 8:40 AM9:20 AMPrevention of Food Allergy: Beyond Peanut w/ Q&A
 9:20 AM9:40 AMTaking this course back to the clinic
 9:40 AM10:00 AMPanel Discussion
 10:00 AM10:30 AMBreak
 10:30 AM11:30 AMDiscussion Breakouts
 10:30 AM11:30 AMFood Allergy Research in the Office Setting
 10:30 AM11:30 AMLogistics of Early Introduction of Peanut and Other Foods
 10:30 AM11:30 AMFuture Directions in Food Allergy Prevention
 10:30 AM11:30 AMFuture Directions in Food Allergy Treatment
 10:30 AM11:30 AMFood Allergy in Adults:  Is Anything different?
Hilton Chicago
720 South Michigan Avenue
Chicago, IL 60605
United States
Housing

The AAAAI has reserved room blocks at the following hotels for your convenience:

Hilton Chicago (all events take place in this facility)

Discounted rate of $189/night + tax

Reservation deadline:  Friday, August 16, 2019

Online reservations:  https://book.passkey.com/go/AAAAI2019

Phone reservations:  (312) 922-4400 – Please reference code “AFA” to receive the AAAAI discounted rate.

The Blackstone (approximately a 1 block walk)

Discounted rate of $249/night + tax

Reservation deadline:  Thursday, August 8, 2019

Online reservations: https://www.marriott.com/event-reservations/reservation-link.mi?id=1556833021201&key=GRP&app=resvlink

Phone reservations:  (800) 505-0261 or (312) 447-0955 – Please reference group code “AAAAI” to receive the AAAAI discounted rate.

All reservations are subject to availability and are on a first-come, first-serve basis.  

Planning Committee

Robert Wood, MD FAAAAI
Johns Hopkins University School of Medicine, Baltimore, MD
Relevant relationships: Aimmune (research grant); Astellas (research grant); DBV Technologies (research grant); HAL-Allergy (research grant); Sanofi (research grant); Regeneron (research grant)

Ashley Devonshire, MD
Northwestern University/Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL
Relevant relationships: None

Kim Mudd, RN MSN CCRP
Johns Hopkins University, Baltimore, MD
Relevant relationships: None

Lily Pien, MD FAAAAI
Cleveland Clinic Foundation, Cleveland, OH
Relevant relationships: None

Yamini Virkud, MD
Massachusetts General Hospital, Boston, MA
Relevant relationships: None

Speaking Faculty

Cecilia Berin, PhD
Mount Sinai School of Medcine, New York City, NY
Relevant relationships: ProtaTherapeutics (advisory board)

J. Andrew Bird, MD FAAAAI
University of Texas Southwestern Medical Center, Dallas, TX
Relevant relationships: DBV Technologies (advisory board, speaker, research grant); Aimmune Therapeutics (advisory board); Pfizer (advisory board); Pharm Olam International (data & safety monitoring board)

Christina Ciaccio, MD FAAAAI
University of Chicago, Chicago, IL
Relevant relationships: Regeneron (advisory board); Aimmune (speaker)

David Fleischer, MD FAAAAI
University of Colorado Medicine/Children’s Hospital Colorado, Aurora, CO
Relevant relationships: Aquestive (consultant); INSYS Therapeutics, Inc. (consultant); AllerGenis (consultant); Nutricia (speaker); Abbott (speaker); Aimmune Therapeutics (research grant); DBV Technologies (consultant, advisory board, research grant)

Marion Groetch, MS RDN
Icahn School of Medicine at Mount Sinai, New York City, NY
Relevant relationships: Nutricia North America (speaker); Mead Johnson (speaker); Abbott (speaker)

Anne Hiegel, APRN
University of Arkansas Medical School/Arkansas Children’s Hospital, Little Rock, AR
Relevant relationships: None

Jackie Isola, RN MS CPNP
Johns Hopkins Hospital, Baltimore, MD
Relevant relationships: None

Stacie Jones, MD
University of Arkansas Medical School/Arkansas Children’s Hospital, Little Rock, AR
Relevant relationships: Aimmune Therapeutics (advisory board, clinical trials); Sanofi, Inc. (clinical trials); DBV Technologies (clinical trials); Astellas, Inc. (clinical trials)

Corinne Keet, MD MS PhD
Johns Hopkins School of Medicine, Baltimore, MD
Relevant relationships: None

John Kelso, MD FAAAAI
Scripps Clinic, San Diego, CA
Relevant relationships: None

Donald Leung, MD PhD FAAAAI
National Jewish Health, Denver, CO
Relevant relationships: Abbvie (advisory board); Aimmune (advisory board); Incyte (advisory board); Novartis (advisory board); Regeneron (advisory board); Sanofi (advisory board); Pfizer (research grant)

Emily McGowan, MD PhD FAAAAI
University of Virginia School of Medicine, Charlottesville, VA
Relevant relationships: Shire (consultant)

Kim Mudd, RN MSN CCRP
Johns Hopkins University, Baltimore, MD
Relevant relationships: None

Sally Noone, RN MSN
Retired
Relevant relationships: None

Anna Nowak-Wegrzyn, MD PhD FAAAAI
Icahn School of Medicine at Mount Sinai, New York City, NY
Relevant relationships: Merck (advisory board); Abbott (speaker); Mead Johnson (speaker); Gerber (advisory board); Alk Abello (clinical trials); Labcorp (advisory board); Astellas (research grant); DBV Technologies (research grant)

Wayne Shreffler, MD PhD FAAAAI
Massachusetts General Hospital, Boston, MA
Relevant relationships: None

Scott Sicherer, MD FAAAAI
Icahn School of Medicine at Mount Sinai, New York City, NY
Relevant relationships: HAL Allergy (research grant)

Jonathan Spergel, MD PhD FAAAAI
Children’s Hospital of Philadelphia, Philadelphia, PA
Relevant relationships: DBV Technologies (advisory board); Regeneron (consultant)

Pamela Steele, MSN CPNP AE-C
University of North Carolina at Chapel Hill Health Care, Chapel Hill, NC
Relevant relationships: None

Carina Venter, PhD RD
University of Colorado/Children’s Hospital Colorado, Aurora, CO
Relevant relationships: Danone (speaker); Mead Johnson (speaker); Nestle (speaker); DBV Technologies (advisory board); Abbott (speaker); Thermo Fisher (research grant)

Brian Vickery, MD FAAAAI
Emory University, Atlanta, GA
Relevant relationships: Thermo Fisher (speaker); Aimmune (advisory board)

Julie Wang, MD FAAAAI
Icahn School of Medicine at Mount Sinai, New York City, NY
Relevant relationships: JDP Therapeutics (advisory board); Aimmune (consultant); DBV Technologies (advisory board)

Robert Wood, MD FAAAAI
Johns Hopkins University School of Medicine, Baltimore, MD
Relevant relationships: Aimmune (research grant); Astellas (research grant); DBV Technologies (research grant); HAL-Allergy (research grant); Sanofi (research grant); Regeneron (research grant)

Content Reviewers

Anne Borgmeyer, RN CPNP AE-C
St. Louis Childrens Hospital, St. Louis, MO
Relevant relationships: None

Brian Kelly, MD
St. Paul Allergy and Asthma, St. Paul, MN
Relevant relationships: None


AAAAI Disclosure Policy

Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters:

  • Employment: Name of employer and job title.
  • Financial interests: All organizations, other than the employer, from which the faculty member or a member of his/her immediate family or household receives annual remuneration in any amount (including grants, honoraria and consulting fees).
  • Research interests: All organizations which support research projects for which the faculty member or member of his/her immediate family or household serves as an investigator.
  • Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
  • Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
  • Gifts: All organizations from which the faculty member or a member of his/her immediate family or household have received a gift of any amount in the last year.
  • Other interests: All interests of the faculty member or a member of his/her immediate family or household that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.

The information disclosed by the speakers and planning committee was reviewed in accordance with the AAAAI Disclosure Policy. All potential conflicts of interest were resolved by the planners, faculty, and reviewers prior to their participation in the development of this activity.



Accreditation Statement

The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

The American Academy of Allergy, Asthma & Immunology designates this live activity for a maximum of 14.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CE Designation Statement

The American Academy of Allergy, Asthma, & Immunology (AAAAI) is a Provider, approved by the California Board of Registered Nursing, Provider #10704, for up to 14.50 Contact Hours.


Credit Claiming Period

Credit claiming for this activity will expire at 11:59 pm on June 30, 2020. Requests to claim credit on or after July 1, 2020 will be subject to an administrative fee.


AAAAI Privacy Policy

To verify your participation in educational activities, you may be asked to provide your name, contact information, and/or other descriptors. The AAAAI will not release this information to outside entities. It may be used internally to inform you of other AAAAI educational activities. If you wish to have your information excluded from this process, please contact us at cme@aaaai.org.


Questions

Activity-related questions should be directed to Deborah Levinson (cme@aaaai.org).

Registration and credit claiming questions should be directed to cme@aaaai.org.

Available Credit

  • 14.50 Attendance
    Attendance credit.
  • 14.50 CE
    CE credit.
  • 14.50 CME
    CME credit.

Accreditation Period

Course opens: 
12/17/2018
Course expires: 
06/30/2020

Price

Cost:
$495.00
Please login or register to take this course.

REGISTRATION CLOSED. THIS MEETING IS SOLD OUT. NO ONSITE REGISTRATIONS WILL BE TAKEN.

PLEASE CLICK HERE FOR INFORMATION ABOUT PRE-ORDERING RECORDINGS OF THIS PROGRAM.


 

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari.

Internet Explorer is no longer supported.